Showing results (1491-1500 of 1,729) with videos related to

Sort By:
Pageof 173
Neuro-Oncology|May 5, 2022
HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant gliomaMarius Felix, Dennis Friedel, Ashok Kumar Jayavelu, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 24, 2025
AMP-activated protein kinase mediates adaptation of glioblastoma cells to conditions of the tumor microenvironmentNadja I Lorenz, Benedikt Sauer, Hans Urban, et al.
American Journal of Health Promotion : AJHP|November 11, 2017
What Factors Explain Bicycling and Walking for Commuting by ELSA-Brasil Participants?Sheila Maria Alvim de Matos, Francisco José Gondim Pitanga, Maria da Conceição C Almeida, et al.
Journal of the National Cancer Institute|December 29, 2020
Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 TrialCéline Callens, Dominique Vaur, Isabelle Soubeyran, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 9, 2023
Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrenceHelmut Plett, Enzo Ricciardi, Vlad Vacaru, et al.
Brain Pathology (Zurich, Switzerland)|November 27, 2023
DistSNE: Distributed computing and online visualization of DNA methylation-based central nervous system tumor classificationKai Schmid, Jannik Sehring, Attila Németh, et al.
Annals of Surgical Oncology|July 7, 2011
A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selectionWen-Juan Tian, Dennis S Chi, Jalid Sehouli, et al.
Plos One|February 7, 2022
Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancerFlorian Heitz, Sotirios Lakis, Philipp Harter, et al.
Future Oncology (London, England)|November 16, 2016
Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancersIrene Karam, Min Yao, Dwight E Heron, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 25, 2024
Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaboratorsDominik Denschlag, Florian Heitz, Jacobus Pfisterer, et al.
Pageof 173